Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)

The summary for the Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required): Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an interest in small business by simultaneously supporting their entrepreneurial development and the conduct of research and development under their direction. This NOFO supports small business concerns (SBCs) in employing and developing researchers as entrepreneurial Program Directors/Principal Investigators (PDs/PIs). In addition to augmenting scientific research staff and supporting research and development efforts at SBCs, a major component of this NOFO is entrepreneurial training, mentoring, and career development of the PD/PI. Optimal PDs/PIs for this award are scientists and professionals with strong research, technology development, and/or healthcare delivery skills and experience, but limited entrepreneurial and independent research project leadership experience. PDs/PIs are expected to grow their entrepreneurial skillset while working in a small business to develop promising technologies and products that align with NIH's mission to improve health and save lives.
Federal Grant Title: Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Education, Health, Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-24-132
Type of Funding: Grant
CFDA Numbers: 93.172, 93.173, 93.213, 93.233, 93.262, 93.273, 93.279, 93.361, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867, 93.879
CFDA Descriptions: Information not provided
Current Application Deadline: April 5th, 2027
Original Application Deadline: April 5th, 2027
Posted Date: April 26th, 2024
Creation Date: April 26th, 2024
Archive Date: May 11th, 2027
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: April 26th, 2024
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/pa-files/PAR-24-132.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical,...
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required)
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health
The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not All...
Women's Reproductive Health Research (WRHR) Career Development Program (K12 Clinical Trial...
The Road to Prevention of Stillbirth Clinical Research Centers (UG1 Clinical Trial Option...
Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk...
Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com